{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:55:22Z","timestamp":1781571322027,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","award":["UL1TR000433"],"award-info":[{"award-number":["UL1TR000433"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["UL1TR000424"],"award-info":[{"award-number":["UL1TR000424"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UCSF-CTSI UL1RR024131"],"award-info":[{"award-number":["UCSF-CTSI UL1RR024131"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK060990"],"award-info":[{"award-number":["U01DK060990"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061028"],"award-info":[{"award-number":["U01DK061028"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061021"],"award-info":[{"award-number":["U01DK061021"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK060980"],"award-info":[{"award-number":["U01DK060980"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK060902"],"award-info":[{"award-number":["U01DK060902"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK060984"],"award-info":[{"award-number":["U01DK060984"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061022"],"award-info":[{"award-number":["U01DK061022"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK060963"],"award-info":[{"award-number":["U01DK060963"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","award":["CTSA UL1RR029879"],"award-info":[{"award-number":["CTSA UL1RR029879"]}],"id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","award":["P20GM109036"],"award-info":[{"award-number":["P20GM109036"]}],"id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007928","name":"Perelman School of Medicine, University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018091","name":"School of Medicine, University of New Mexico","doi-asserted-by":"publisher","award":["K24AI146137"],"award-info":[{"award-number":["K24AI146137"]}],"id":[{"id":"10.13039\/100018091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018091","name":"School of Medicine, University of New Mexico","doi-asserted-by":"publisher","award":["R01AG074989"],"award-info":[{"award-number":["R01AG074989"]}],"id":[{"id":"10.13039\/100018091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018091","name":"School of Medicine, University of New Mexico","doi-asserted-by":"publisher","award":["T32DK007006"],"award-info":[{"award-number":["T32DK007006"]}],"id":[{"id":"10.13039\/100018091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018091","name":"School of Medicine, University of New Mexico","doi-asserted-by":"publisher","award":["NM R01DK119199"],"award-info":[{"award-number":["NM R01DK119199"]}],"id":[{"id":"10.13039\/100018091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000003"],"award-info":[{"award-number":["UL1TR000003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","award":["UL1TR000439"],"award-info":[{"award-number":["UL1TR000439"]}],"id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","award":["GCRC M01 RR-16500"],"award-info":[{"award-number":["GCRC M01 RR-16500"]}],"id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xkme.2025.101159","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:10:20Z","timestamp":1761433820000},"page":"101159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renin-Angiotensin System Inhibitors in Patients With Nonproteinuric Chronic Kidney Disease and Kidney Outcomes: Findings From the CRIC Study"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-9275","authenticated-orcid":false,"given":"Rachel","family":"Shulman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panduranga S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallabh O.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2025.101159_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12325-020-01568-8","article-title":"Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review","volume":"38","author":"Murton","year":"2021","journal-title":"Adv Ther"},{"issue":"13","key":"10.1016\/j.xkme.2025.101159_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Writing Group for the CKD Prognosis Consortium","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.xkme.2025.101159_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1755-1536-3-7","article-title":"The role of renin angiotensin system inhibition in kidney repair","volume":"3","author":"van der Meer","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"10.1016\/j.xkme.2025.101159_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ki.1994.52","article-title":"The paradox of the renin-angiotensin system in chronic renal disease","volume":"45","author":"Rosenberg","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2025.101159_bib5","article-title":"Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"9176","key":"10.1016\/j.xkme.2025.101159_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.xkme.2025.101159_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.xkme.2025.101159_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.xkme.2025.101159_bib9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7 suppl 2","key":"10.1016\/j.xkme.2025.101159_bib10","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"10.1016\/j.xkme.2025.101159_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"issue":"9069","key":"10.1016\/j.xkme.2025.101159_bib12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.xkme.2025.101159_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101159_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101159_bib15","doi-asserted-by":"crossref","first-page":"60A","DOI":"10.1016\/S0002-9149(88)80087-0","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"62","author":"Swedberg","year":"1988","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101159_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2011.12.056","article-title":"Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial","volume":"167","author":"Bowling","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101159_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HCO.0000000000000173","article-title":"Dual renin-angiotensin system blockade and outcome benefits in hypertension: a narrative review","volume":"30","author":"Mann","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"19","key":"10.1016\/j.xkme.2025.101159_bib18","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMoa2103753","article-title":"Race, genetic ancestry, and estimating kidney function in CKD","volume":"385","author":"Hsu","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.xkme.2025.101159_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101159_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hfc.2008.03.008","article-title":"Epidemiology of chronic kidney disease in heart failure","volume":"4","author":"Ahmed","year":"2008","journal-title":"Heart Fail Clin"},{"issue":"5","key":"10.1016\/j.xkme.2025.101159_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000368915","article-title":"Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study","volume":"40","author":"Rahman","year":"2014","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101159_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2018.02.362","article-title":"Obesity, metabolic abnormality, and progression of CKD","volume":"72","author":"Yun","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2025.101159_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94467-z","article-title":"Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study","volume":"11","author":"Tsuchida-Nishiwaki","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.xkme.2025.101159_bib24","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1681\/ASN.2018040344","article-title":"Racial disparities in nephrology consultation and disease progression among Veterans with CKD: an observational cohort study","volume":"29","author":"Suarez","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2025.101159_bib25","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"issue":"5","key":"10.1016\/j.xkme.2025.101159_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2018.02.364","article-title":"Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"72","author":"Koye","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2025.101159_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2147\/CLEP.S360395","article-title":"The association between statin use and risk of chronic kidney disease in community-dwelling older people in Shanghai, China","volume":"14","author":"Zhao","year":"2022","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101159_bib28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2013.08.028","article-title":"Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"63","author":"Yang","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2025.101159_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/aje\/kwaa225","article-title":"Common methods for handling missing data in marginal structural models: what works and why","volume":"190","author":"Leyrat","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"19","key":"10.1016\/j.xkme.2025.101159_bib30","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.xkme.2025.101159_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1681\/ASN.0000000000000426","article-title":"Association between acute declines in eGFR during renin-angiotensin system inhibition and risk of adverse outcomes","volume":"35","author":"Ku","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101159_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.xkme.2025.101159_bib33","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/HYPERTENSIONAHA.124.23184","article-title":"Cardiac effects of renin-angiotensin system inhibitors in nonproteinuric CKD","volume":"81","author":"Shulman","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.xkme.2025.101159_bib34","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2147\/DMSO.S243170","article-title":"Empagliflozin protects against proximal renal tubular cell injury induced by high glucose via regulation of hypoxia-inducible factor 1-alpha","volume":"13","author":"Ndibalema","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"11","key":"10.1016\/j.xkme.2025.101159_bib35","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.3390\/biomedicines11112984","article-title":"Kidney renin release under hypoxia and its potential link with nitric oxide: a narrative review","volume":"11","author":"Kong","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.xkme.2025.101159_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103942","article-title":"Hypoxia and chronic kidney disease","volume":"77","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"issue":"23","key":"10.1016\/j.xkme.2025.101159_bib37","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.xkme.2025.101159_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/08037051003802475","article-title":"Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function","volume":"19","author":"Shiga","year":"2010","journal-title":"Blood Press"},{"issue":"23","key":"10.1016\/j.xkme.2025.101159_bib39","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2025.101159_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2019.05.055","article-title":"Renin-angiotensin system inhibition following transcatheter aortic valve replacement","volume":"74","author":"Rodriguez-Gabella","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101159_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.118.11065","article-title":"Role of renin-angiotensin-aldosterone system activation in promoting cardiovascular fibrosis and stiffness","volume":"72","author":"Jia","year":"2018","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.xkme.2025.101159_bib42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin-angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.xkme.2025.101159_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.HYP.36.4.575","article-title":"Renin-angiotensin system blockade improves endothelial dysfunction in hypertension","volume":"36","author":"Goto","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.xkme.2025.101159_bib44","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.12659\/MSM.903660","article-title":"Albuminuria and endothelial dysfunction in patients with non-diabetic chronic kidney disease","volume":"23","author":"Huang","year":"2017","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.xkme.2025.101159_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12882-020-01792-y","article-title":"Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes","volume":"21","author":"Nichols","year":"2020","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2025.101159_bib46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.xkme.2025.101159_bib47","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1517\/14656566.2011.602068","article-title":"The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"12","author":"Grassi","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"9200","key":"10.1016\/j.xkme.2025.101159_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.xkme.2025.101159_bib49","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2025.101159_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.27.1.195","article-title":"Nonalbuminuric renal insufficiency in type 2 diabetes","volume":"27","author":"MacIsaac","year":"2004","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.xkme.2025.101159_bib51","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","article-title":"Clinical significance of nonalbuminuric renal impairment in type 2 diabetes","volume":"29","author":"Penno","year":"2011","journal-title":"J Hypertens"},{"issue":"17","key":"10.1016\/j.xkme.2025.101159_bib52","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2025.101159_bib53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41440-019-0234-6","article-title":"The effects of renin-angiotensin system inhibitors on mortality, cardiovascular events, and renal events in hypertensive patients with diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Kunimura","year":"2019","journal-title":"Hypertens Res"},{"issue":"19","key":"10.1016\/j.xkme.2025.101159_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027099","article-title":"Comparison of pharmacy refill data with chemical adherence testing in assessing medication nonadherence in a safety net hospital setting","volume":"11","author":"Osula","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"3 suppl 1","key":"10.1016\/j.xkme.2025.101159_bib55","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.12.001","article-title":"US Renal Data System 2022 annual data report: epidemiology of kidney disease in the United States","volume":"81","author":"Johansen","year":"2023","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:33:03Z","timestamp":1781569983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2590059525001955"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101159","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin System Inhibitors in Patients With Nonproteinuric Chronic Kidney Disease and Kidney Outcomes: Findings From the CRIC Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101159"}}